---
title: "RBL2"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene: RBL2"
tags: ['RBL2', 'CellCycleRegulation', 'TumorSuppression', 'CancerTherapy', 'PrognosticMarkers', 'GeneticMutations', 'Oncogene', 'DrugResponse']
---

# Gene: RBL2

## Information

- **Gene:** RBL2
- **Function:** Negative regulator of the cell cycle, mainly regulated in the G1 phase. It is involved in the regulation of DNA replication and repair, and has been associated with tumor suppression. 
- **Aliases:** 
    - p130
    - Rb-like protein 2
- **External IDs:**
    - HGNC: 9864
    - NCBI Entrez: 5934
    - Ensembl: ENSG00000065665
    - OMIM: 602860
    - UniProtKB/Swiss-Prot: Q08999

## Mutations

### AA mutation list and mutation type with dbSNP ID

|AA Mutation|Mutation Type|dbSNP ID|
|---|---|---|
|H70Q|Missense|rs371537452|
|P329H|Missense|rs34006823|
|V236A|Missense|rs63750858|

### Somatic SNVs/InDels with dbSNP ID

|Type|dbSNP ID|
|---|---|
|SNV|rs113169115|
|SNV|rs527616662|
|SNV|rs755193972|

## Related Diseases

The RBL2 gene has been implicated in the following diseases:
- Lung Cancer
- Breast Cancer
- Ovarian Cancer

## Treatment and Prognosis

Studies have suggested that alterations in RBL2 could be used as prognostic markers and targets for cancer therapy. 

## Drug Response

There is currently no known drug response associated with alterations in RBL2.

## References
- Giacinti, C., & Giordano, A. (2006). RB and cell cycle progression. Oncogene, 25(38), 5220-5227. doi: 10.1038/sj.onc.1209625
- Kuwahara, Y., & Charboneau, A. L. (2020). Molecular players in cell cycle control: an overview of algorithms and cell-based assays. Drug discovery today, 25(7), 1182-1205. doi: 10.1016/j.drudis.2020.03.007

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**